Standard Biotools (LAB) EBT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.64 Bn | 221.57 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 144.47 Bn | 140.12 Bn | 3.61 Bn | -211.00 |
| 3 | Agilent Technologies | 40.90 Bn | 39.15 Bn | 1.04 Bn | 1,575.00 |
| 4 | Illumina | 30.90 Bn | 29.73 Bn | 770.00 Mn | 3,000.00 |
| 5 | Revvity | 13.85 Bn | 12.82 Bn | 416.87 Mn | -138.00 |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | -730.00 |
| 7 | Bio-Rad Laboratories | 10.12 Bn | 8.50 Bn | 345.80 Mn | 30,357.00 |
| 8 | Repligen | 9.28 Bn | 8.27 Bn | 110.04 Mn | -871.00 |
| 9 | 10x Genomics | 8.70 Bn | 8.14 Bn | 112.50 Mn | 2,904.00 |
| 10 | Standard Biotools | 282.88 Mn | -193.84 Mn | 10.54 Mn | -4,612.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,612.00 |
| Mar 31, 2026 | -311.00 |
| Dec 31, 2025 | -1,570.00 |
| Sep 30, 2025 | -5,075.00 |
| Jun 30, 2025 | 26,297.00 |
| Mar 31, 2025 | 17,385.00 |
| Sep 30, 2024 | -4,085.00 |
| Jun 30, 2024 | -5,316.00 |
| Mar 31, 2024 | -784.00 |
| Dec 31, 2023 | -3,254.00 |
| Sep 30, 2023 | -6,692.00 |
| Jun 30, 2023 | -616.00 |
| Mar 31, 2023 | -568.00 |
| Dec 31, 2022 | -3,887.00 |
| Sep 30, 2022 | -6,447.00 |
| Jun 30, 2022 | -29,415.00 |
| Mar 31, 2022 | -20,557.00 |
| Sep 30, 2021 | -424.00 |
| Jun 30, 2021 | 244.00 |
| Mar 31, 2021 | -533.00 |